Imatge de la portada

NASH and Systemic Complications

Nonalcoholic fatty liver disease (NAFLD) is known as the hepatic manifestation of the metabolic syndrome, and while most patients develop simple steatosis, up to one-third can develop nonalcoholic steatohepatitis (NASH). NASH is a chronic inflammatory condition of the liver that can further progress...

Descripció completa

Guardat en:
Format: Online
Idioma:anglès
Publicat: MDPI - Multidisciplinary Digital Publishing Institute 2022
Matèries:
NAFLD
mouse models
multifactorial disease
translational value
non-alcoholic fatty liver disease
steatohepatitis
NASH
cognitive impairment
memory dysfunction
Alzheimer’s disease
neurodegeneration
liver stiffness
liver steatosis
controlled attenuation parameter
transient elastography
MRI PDFF
MR spectroscopy
non-alcoholic steatohepatitis (NASH)
tunneling nanotubes (TNTs)
primary hepatocytes
organelle transfer
mesenchymal stromal cells
aminopyrine
microsomal
liver function
breath test
nonalcoholic fatty liver disease
nonalcoholic steatohepatitis
extracellular vesicles
magnesium (Mg2+)
obesity
insulin resistance (IR)
type 2 diabetes mellitus (T2DM)
hypertension
cardiovascular diseases (CVD)
non-alcoholic steatohepatitis
intestinal permeability
microbiota
probiotics
physical exercise
fecal microbiota transplantation
hepatocellular carcinoma
pathogenesis
extra-hepatic outcome
organ-on-a-chip
artificial intelligence
liver disease
GLP-1 agonist
SGLT-2 inhibitor
type 2 diabetes
innate immune system
adaptive immune system
metabolic syndrome
fatty liver
leptin
n/a
thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general
Accés en línia:ONIX_20220224_9783036529790_116
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

ONIX_20220224_9783036529790_116

Ítems similars